CMND stock Statistics — Clearmind Medicine Inc. filings, insiders & smart money

Price chart (1D to 10Y)

Licensed market data — shown to members, not published to the open web.

Beta: Sign in
Shares outstandingAs of 2026-01-19 · filed common shares: 158.07K
Shares float: Sign in
Float %: Sign in
Insider ownership: —
Institutional ownership: Sign in
Short interestShare of shares outstanding, at settlement: 15.93%
Short ratioDays to cover, as published by FINRA: 1.00
Short volume (5D)Share of FINRA reporting-facility volume sold short, daily flow: 37.10%
Short volume (20D)Share of FINRA reporting-facility volume sold short, daily flow: 35.90%
Avg volume (10D)

Source: SEC filings. Information and analytics, not investment advice.

Sign in

Avg volume (3 months)

Gross margin: —
Operating margin: —
Net margin: —
EBITDA margin: —
Return on equityNet income (FY Oct 25) ÷ average shareholders equity: -179.39%
Return on assetsNet income (FY Oct 25) ÷ average total assets: -57.83%

Cash & equivalentsas of Oct 25: $3.92M
Total cash: Sign in
Total debtBorrowings + finance and operating lease liabilities, as of Oct 25: $18.80K
Debt / equityas of Oct 25: 1.58%
Current ratioas of Oct 25: 1.22
Quick ratio: —
Operating cash flowFY Oct 25: -$4.73M
Free cash flowUnadjusted FCF = CFO − capex · FY Oct 25: -$4.73M
TTM revenue / diluted share: —